TMEM59 and Alzheimer disease: The downregulation of TMEM59 may disrupt glycoprotein maturation and trafficking, impairing protein-folding quality control mechanisms and exacerbating proteostatic stress—a phenomenon previously linked to AD pathology (Meng et al., 2020).